{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:26:21Z","timestamp":1790375181003,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The 2024 University Teacher Innovation Fund Project","award":["2024B-024"],"award-info":[{"award-number":["2024B-024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05697-3","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:36:54Z","timestamp":1746157014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Yahong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"5","key":"5697_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2010.40","volume":"6","author":"AW Michels","year":"2010","unstructured":"Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6(5):270\u20137. https:\/\/doi.org\/10.1038\/nrendo.2010.40. Epub 2010 Mar 23.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"5697_CR2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMra1713301","volume":"378","author":"ES Husebye","year":"2018","unstructured":"Husebye ES, Anderson MS, K\u00e4mpe O. Autoimmune polyendocrine syndromes. N Engl J Med. 2018;378(12):1132\u201341. https:\/\/doi.org\/10.1056\/NEJMra1713301.","journal-title":"N Engl J Med"},{"issue":"3","key":"5697_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.23750\/abm.v88i3.5898","volume":"88","author":"G Zirilli","year":"2017","unstructured":"Zirilli G, Santucci S, Cuzzup\u00e8 C, Corica D, Pitrolo E, Salzano G. Peculiarities of autoimmune polyglandular syndromes in children and adolescents. Acta Biomed. 2017;88(3):271\u20135. https:\/\/doi.org\/10.23750\/abm.v88i3.5898.","journal-title":"Acta Biomed"},{"issue":"2","key":"5697_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0889-8529(01)00010-x","volume":"31","author":"A Falorni","year":"2002","unstructured":"Falorni A, Laureti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am. 2002;31(2):369\u2013. https:\/\/doi.org\/10.1016\/s0889-8529(01)00010-x. \u200989, vii.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"5697_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-09-0044","volume":"161","author":"GJ Kahaly","year":"2009","unstructured":"Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol. 2009;161(1):11\u201320. https:\/\/doi.org\/10.1530\/EJE-09-0044. Epub 2009 May 1.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"5697_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng1297-393","volume":"17","author":"K Nagamine","year":"1997","unstructured":"Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene. Nat Genet. 1997;17(4):393\u20138. https:\/\/doi.org\/10.1038\/ng1297-393.","journal-title":"Nat Genet"},{"issue":"2","key":"5697_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","volume":"13","author":"M Cutolo","year":"2014","unstructured":"Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev. 2014;13(2):85\u2013. https:\/\/doi.org\/10.1016\/j.autrev.2013.07.006. Epub 2013 Sep 18. \u20099.","journal-title":"Autoimmun Rev"},{"key":"5697_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445\u201389. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101212.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"5697_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/children10030588","volume":"10","author":"R Paparella","year":"2023","unstructured":"Paparella R, Menghi M, Micangeli G, Leonardi L, Profeta G, Tarani F, Petrella C, Ferraguti G, Fiore M, Tarani L. Autoimmune polyendocrine syndromes in the pediatric age. Child (Basel). 2023;10(3):588. https:\/\/doi.org\/10.3390\/children10030588.","journal-title":"Child (Basel)"},{"issue":"4","key":"5697_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","volume":"9","author":"M Neufeld","year":"1980","unstructured":"Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann. 1980;9(4):154\u201362.","journal-title":"Pediatr Ann"},{"issue":"1","key":"5697_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12887-020-02030-y","volume":"20","author":"BM Minka","year":"2020","unstructured":"Minka BM, Sibetcheu TA, Sap SNU, Bissa MC. Chronic cutaneous candidiasis in children: should we stop there? Report of two cases associated with auto-immune polyendocrinopathy syndrome type I. BMC Pediatr. 2020;20(1):128. https:\/\/doi.org\/10.1186\/s12887-020-02030-y.","journal-title":"BMC Pediatr"},{"issue":"1","key":"5697_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","volume":"17","author":"CJ Guo","year":"2018","unstructured":"Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1). Autoimmun Rev. 2018;17(1):78\u201385. https:\/\/doi.org\/10.1016\/j.autrev.2017.11.012. Epub 2017 Nov 4.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5697_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/jcem-62-3-455","volume":"62","author":"NK Maclaren","year":"1986","unstructured":"Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune Addison\u2019s disease is linked to human leukocyte antigens-DR3 and\/or DR4, except when associated with type I autoimmune polyglandular syndrome. J Clin Endocrinol Metab. 1986;62(3):455\u20139. https:\/\/doi.org\/10.1210\/jcem-62-3-455.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5697_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","volume":"41","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41(1):91\u20138. https:\/\/doi.org\/10.1007\/s40618-017-0740-9. Epub 2017 Aug 17.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"5697_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1515\/jpem-2022-0050","volume":"35","author":"B Bou\u00e7a","year":"2022","unstructured":"Bou\u00e7a B, Nogueira A, Caetano J, Cardoso R, Dinis I, Mirante A. Clinical characteristics of polyglandular autoimmune syndromes in pediatric age: an observational study. J Pediatr Endocrinol Metab. 2022;35(4):477\u201380. https:\/\/doi.org\/10.1515\/jpem-2022-0050. Print 2022 Apr 26.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"5697_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/08916934.2019.1698553","volume":"53","author":"X Ji","year":"2020","unstructured":"Ji X, Wan J, Chen R, Wang H, Huang L, Wang S, Su Z, Xu H. Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in graves\u2019 disease, which May be related to elevated-TRAb levels. Autoimmunity. 2020;53(2):78\u201385. https:\/\/doi.org\/10.1080\/08916934.2019.1698553. Epub 2019 Dec 6.","journal-title":"Autoimmunity"},{"issue":"3","key":"5697_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481\u201397. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.011.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 1","key":"5697_CR18","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.4103\/2230-8210.155404","volume":"19","author":"CS Krishna","year":"2015","unstructured":"Krishna CS, Srikanta S. Type 1 diabetes pathogenesis - Prevention??? Indian J Endocrinol Metab. 2015;19(Suppl 1):S58\u201363. https:\/\/doi.org\/10.4103\/2230-8210.155404.","journal-title":"Indian J Endocrinol Metab"},{"issue":"26","key":"5697_CR19","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE, Myasthenia Gravis. N Engl J Med. 2016;375(26):2570\u201381. https:\/\/doi.org\/10.1056\/NEJMra1602678.","journal-title":"N Engl J Med"},{"issue":"8","key":"5697_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H. Clinical features, pathogenesis, and treatment of myasthenia Gravis: a supplement to the guidelines of the German neurological society. J Neurol. 2016;263(8):1473\u201394. https:\/\/doi.org\/10.1007\/s00415-016-8045-z. Epub 2016 Feb 17.","journal-title":"J Neurol"},{"issue":"6","key":"5697_CR21","doi-asserted-by":"publisher","first-page":"101344","DOI":"10.1016\/j.beem.2019.101344","volume":"33","author":"GJ Kahaly","year":"2019","unstructured":"Kahaly GJ, Frommer L. Autoimmune polyglandular diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101344. https:\/\/doi.org\/10.1016\/j.beem.2019.101344. Epub 2019 Oct 4.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"5697_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13052-023-01502-y","volume":"49","author":"M Arrigoni","year":"2023","unstructured":"Arrigoni M, Cavarzere P, Nicolussi Principe L, Gaudino R, Antoniazzi F. Autoimmune adrenal insufficiency in children: a hint for polyglandular syndrome type 2? Ital J Pediatr. 2023;49(1):94. https:\/\/doi.org\/10.1186\/s13052-023-01502-y. Published 2023 Jul 29.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"5697_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ejpn.2014.02.006","volume":"18","author":"O Duman","year":"2014","unstructured":"Duman O, Koken R, Baran RT, Haspolat S, Topaloglu H. Infantile anti-MuSK positive myasthenia Gravis in a patient with autoimmune polyendocrinopathy type 3. Eur J Paediatr Neurol. 2014;18(4):526\u20138. https:\/\/doi.org\/10.1016\/j.ejpn.2014.02.006.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"5697_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4274\/jcrpe.1394","volume":"7","author":"H K\u0131rm\u0131z\u0131bekmez","year":"2015","unstructured":"K\u0131rm\u0131z\u0131bekmez H, Ye\u015filtepe Mutlu RG, Demirk\u0131ran Urganc\u0131 N, \u00d6ner A. Autoimmune polyglandular syndrome type 2: a rare condition in childhood. J Clin Res Pediatr Endocrinol. 2015;7(1):80\u20132. https:\/\/doi.org\/10.4274\/jcrpe.1394.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5697_CR25","doi-asserted-by":"publisher","DOI":"10.32641\/andespediatr.v92i6.3484","author":"C Arteta-Acosta","year":"2021","unstructured":"Arteta-Acosta C, Kraus J, Galilea N, Prado P, Azocar M. Andes Pediatr. 2021;92(6):911\u20136. https:\/\/doi.org\/10.32641\/andespediatr.v92i6.3484. Diabetes mellitus tipo 1 y enfermedad de Graves Basedow, un caso de S\u00edndrome Poliglandular Autoinmune [Type 1 diabetes mellitus and Graves Basedow\u2019s disease, a case of Autoimmune Polyglandular Syndrome]."},{"issue":"3","key":"5697_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.18544\/PEDM-23.03.0088","volume":"23","author":"K Klenczar","year":"2017","unstructured":"Klenczar K, Deja G, Kalina-Faska B, Jarosz-Chobot P. [Myasthenia Gravis, Graves-Basedow disease and other autoimmune diseases in patient with diabetes type 1 - APS-3 case report, therapeutic complications]. Pediatr Endocrinol Diabetes Metab. 2017;23(3):159\u201364. https:\/\/doi.org\/10.18544\/PEDM-23.03.0088.","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"issue":"S1","key":"5697_CR27","first-page":"132","volume":"39","author":"SNR Bunari","year":"2024","unstructured":"Bunari SNR, Teik TS, CO-OCCURRENCE OF OCULAR MYASTHENIA GRAVIS, TYPE 1 DIABETES MELLITUS AND GRAVES\u2019 THYROTOXICOSIS IN A YOUNG CHILD. J ASEAN Federation Endocr Soc. 2024;39(S1):132\u2013132.","journal-title":"J ASEAN Federation Endocr Soc"},{"issue":"4","key":"5697_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3936\/j.issn.1002","volume":"41","author":"YQ Guo","year":"2015","unstructured":"Guo YQ, Chen YU, Chen DX, et al. A case report of the Co - existence of myasthenia Gravis, diabetes mellitus, graves\u2019 disease, and thymic Hyperplasia[J]. Chin J Nerv Mental Dis. 2015;41(4):247\u20139. https:\/\/doi.org\/10.3936\/j.issn.1002.\u2013\u20090152.2015.04.013.","journal-title":"Chin J Nerv Mental Dis"},{"key":"5697_CR29","doi-asserted-by":"publisher","unstructured":"Ashida K, Gobaru M, Nasu-Yoshinobu S, Nagayama A, Kabashima M, Iwata S, Hasuzawa N, Tsuruta M, Wada N, Nakayama H, Motomura S, Tajiri Y, Nomura M. July. Supplemental Table: The reference list of case reports on autoimmune polyendocrine syndrome type 3 with myasthenia gravis, which were either written in Japanese or presented at conferences held in Japan. 2019. https:\/\/doi.org\/10.6084\/m9.figshare.8982413.v1","DOI":"10.6084\/m9.figshare.8982413.v1"},{"key":"5697_CR30","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.12659\/AJCR.918996","volume":"20","author":"M Gobaru","year":"2019","unstructured":"Gobaru M, Ashida K, Yoshinobu S, Nagayama A, Kabashima M, Iwata S, Hasuzawa N, Tsuruta M, Wada N, Nakayama H, Motomura S, Tajiri Y, Nomura M. Human leukocyte antigen (HLA) Subtype-Dependent development of myasthenia Gravis, type-1 diabetes mellitus, and Hashimoto disease: A case report of autoimmune polyendocrine syndrome type 3. Am J Case Rep. 2019;20:1709\u201314. https:\/\/doi.org\/10.12659\/AJCR.918996.","journal-title":"Am J Case Rep"},{"issue":"1","key":"5697_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/003693308803300112","volume":"33","author":"ST Green","year":"1988","unstructured":"Green ST, Ng JP, Chan-Lam D. Insulin-dependent diabetes mellitus, myasthenia Gravis, pernicious anaemia, autoimmune thyroiditis and autoimmune adrenalitis in a single patient. Scott Med J. 1988;33(1):213\u20134. https:\/\/doi.org\/10.1177\/003693308803300112.","journal-title":"Scott Med J"},{"issue":"3","key":"5697_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mus.24635","volume":"52","author":"SU De Marchi","year":"2015","unstructured":"De Marchi SU, Cecchin E, De Marchi S. Autoimmune spontaneous chronic urticaria and generalized myasthenia Gravis in a patient with polyglandular autoimmune syndrome type 3. Muscle Nerve. 2015;52(3):440\u20134. https:\/\/doi.org\/10.1002\/mus.24635.","journal-title":"Muscle Nerve"},{"issue":"6","key":"5697_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/mus.21466","volume":"40","author":"NK Briscoe","year":"2009","unstructured":"Briscoe NK, Mezei MM. Polyglandular autoimmune syndrome type 3 in a patient with ocular myasthenia Gravis. Muscle Nerve. 2009;40(6):1064\u20135. https:\/\/doi.org\/10.1002\/mus.21466.","journal-title":"Muscle Nerve"},{"issue":"1","key":"5697_CR34","doi-asserted-by":"publisher","first-page":"e210073","DOI":"10.1530\/ETJ-21-0073","volume":"11","author":"CF Mooij","year":"2022","unstructured":"Mooij CF, Cheetham TD, Verburg FA, Eckstein A, Pearce SH, L\u00e9ger J, van Trotsenburg ASP. 2022 European thyroid association guideline for the management of pediatric graves\u2019 disease. Eur Thyroid J. 2022;11(1):e210073. https:\/\/doi.org\/10.1530\/ETJ-21-0073.","journal-title":"Eur Thyroid J"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05697-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:36:56Z","timestamp":1746157016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05697-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05697-3","relation":{"references":[{"id-type":"doi","id":"10.32641\/andespediatr.v92i6.3484","asserted-by":"subject"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was granted by the Institutional Medical Ethics Committee of the Second Hospital & Clinical Medical School, Lanzhou University (No. 2025\u00a0A-046). Written informed consent was obtained from the legal guardian(s) of the pediatric patient prior to participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The parents of this patient consented to the publication of the case and any accompanying images with written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"351"}}